Exact Sciences
EXAS
#1384
Rank
HK$102.01 B
Marketcap
HK$552.12
Share price
2.34%
Change (1 day)
-6.67%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$27.13 B

According to Exact Sciences's latest financial reports the company's total liabilities are HK$27.13 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$25.97 B4.43%
2022-12-31HK$24.87 B-3.25%
2021-12-31HK$25.70 B23.29%
2020-12-31HK$20.85 B119.87%
2019-12-31HK$9.48 B43.66%
2018-12-31HK$6.60 B981.35%
2017-12-31HK$0.61 B88.6%
2016-12-31HK$0.32 B12.36%
2015-12-31HK$0.28 B55.77%
2014-12-31HK$0.18 B110.88%
2013-12-31HK$87.71 M-16.33%
2012-12-31HK$0.10 B0.29%
2011-12-31HK$0.10 B-19.85%
2010-12-31HK$0.13 B-14.53%
2009-12-31HK$0.15 B136.33%
2008-12-31HK$64.56 M-0.41%
2007-12-31HK$64.83 M-6.44%
2006-12-31HK$69.29 M-32.41%
2005-12-31HK$0.10 B-19.21%
2004-12-31HK$0.12 B-27.2%
2003-12-31HK$0.17 B90.42%
2002-12-31HK$91.54 M184.05%
2001-12-31HK$32.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$2.68 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.79 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.17 B-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$474.28 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France